Synthesis of ribavirin 1,2,3- and 1,2,4-triazolyl analogs with changes at the amide and cytotoxicity in breast cancer cell lines

Nucleosides Nucleotides Nucleic Acids. 2023;42(1):38-64. doi: 10.1080/15257770.2022.2107218. Epub 2022 Aug 5.

Abstract

We report the synthesis and cytotoxicity in MCF-7 and MDA-MB-231 breast cancer cells of novel 1,2,3- and 1,2,4-triazolyl analogs of ribavirin. We modified ribavirin's carboxamide moiety to test the effects of lipophilic groups. 1-β-D-Ribofuranosyl-1H-1,2,3-triazoles were prepared using Click Chemistry, whereas an unprecedented application of a prior 1,2,4-triazole ring synthesis was used for 1-β-D-ribofuranosyl-1H-1,2,4-triazole analogs. Though cytotoxicity was mediocre and there was no correlation with lipophilicity, we discovered that a structurally similar concentrative nucleoside transporter 2 (CNT2) inhibitor was modestly cytotoxic (MCF-7 IC50 of 42 µM). These syntheses could be used to efficiently investigate variation in the nucleobase.

Keywords: Nucleoside analogs; click chemistry; initiation factor; triazole.

MeSH terms

  • Amides
  • Antineoplastic Agents* / pharmacology
  • Breast Neoplasms*
  • Female
  • Humans
  • MCF-7 Cells
  • Ribavirin
  • Structure-Activity Relationship
  • Triazoles

Substances

  • Ribavirin
  • Amides
  • Antineoplastic Agents
  • Triazoles